The discovery in the Journal of Clinical Investigation, could lead to new mantle cell lymphoma drugs as well as a better understanding of h...

The Hyderabad-based company said its product is therapeutically equivalent to Takeda Pharmaceuticals' Velcade for Injection.

The drug, a generic version of reference listed drug Velcade, will be manufactured at Zydus Hospira, Gujarat.

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 15529.31 Crore) operating in Pharmaceutic...

Tata Motors said it has bagged a contract for 65 electric vehicles from Kerala State Electricity Board. The order includes 60 Tigor EVs and...

Revlimid had annual sales of $2.3 billion as of December 2021, according to IQVIA data. The generic version of Revlimid will be available i...

"Ibrutinib belongs to a class of drugs known as kinase inhibitors and is used to treat certain cancers, such as mantle cell lymphoma or mar...

The Hyderabad-based firm said the first dose under the phase-III trials was given to a patient in the city-based Yashoda Hospitals.

The country's largest lender reported an 80.15 per cent jump in its standalone profit after tax (PAT) of Rs 6,451 crore in the three months...

Natco, along with its marketing partner Arrow International previously settled the Paragraph IV litigation related to the product with Celg...

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of ...

Ponzi scheme fraudster Bernie Madoff's son, Andrew along with his late brother Mark, exposed their father's fraud.

Piramal Life Sciences, the listed research and development (R&D) subsidiary of Piramal Healthcare, is hoping to hit the market with its fir...